What's Next?', ITV News meets families and teens impacted by the drug as the debate over whether to make it a Class A ...

Drugs for inflammatory conditions drove nearly half of spending in commercial plans last year, a new report shows. Express Scripts released its annual Drug Trend Report, which analyzes costs and ...

44.7 percent of angiotensin receptor blocker initiators were continuously persistent to original drug class at three years.

Eliminating the protected classes of medications for Medicare Part D plans could give insurers more leverage to negotiate rebates, but may have a limited financial payoff, according to a new analysis.

An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...

The federal government has backed off a proposal that would have let Medicare Part D prescription drug plans deny coverage for therapies in six "protected" classes of drugs, including those for cancer ...

Scientists have identified two molecules that could help treat leukemia, in a way that’s far less damaging to healthy cells than existing chemotherapy. The compounds work using a different mechanism ...

Two new classes of HIV drugs are poised to hit the market in 2007, signalling what many say is a watershed in HIV treatment, second only to the introduction of cocktail therapy more than a decade ago.

Fungal infections kill millions of people each year, and modern medicine is struggling to keep up. But researchers at ...

Researchers looked specifically at head-to-head randomized clinical trials of next-in-class cancer drugs against existing agents in the same class. Less than one-quarter of next-in-class cancer drugs ...

An experimental Viking Therapeutics obesity drug that hits the same targets as a commercialized Eli Lilly medication has clinical data showing it led to an average 13.1% weight loss after 13 weeks of ...